Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Bruce Jancin

  • 1
    News

    Presepsin can rule out invasive bacterial infection in infants

    August 16, 2019

    LJUBLJANA, SLOVENIA – Novel test addresses unmet need for biomarker for invasive bacterial infection.

  • News

    ‘Substantial burden’ of enterovirus meningitis in young infants

    August 16, 2019

    LJUBLJANA, SLOVENIA – “Not a single one of the patients with enterovirus/human parechovirus meningitis had a secondary bacterial infection – and that has important implications for management of our antibiotic stewardship programs,” said Dr. Seilesh Kadambari.

  • 1
    News

    Novel score spots high-risk febrile children in ED

    August 13, 2019

    LJUBLJANA, SLOVENIA – The age-adapted pediatric quick Sequential Organ Failure Assessment score had a 99.6% negative predictive value.

  • News

    Hospital slashes S. aureus vancomycin resistance

    August 7, 2019

    LJUBLJANA, SLOVENIA – Staphylococcus aureus resistance to vancomycin is not a one-way street ending in a cliff plunge.

  • 1
    News

    Statins crush early seizure risk poststroke

    July 18, 2019

    BANGKOK – Statin initiation upon hospitalization for acute ischemic stroke was linked to a major antiseizure benefit in a Japanese study.

  • 1
    News

    What’s new in pediatric sepsis

    June 26, 2019

    LJUBLJANA, SLOVENIA – Don’t obsess about “Golden Hour” for delivering sepsis treatment bundle, expert advises.

  • 1
    News

    Rapid assay distinguishes viral from bacterial infection

    June 14, 2019

    LJUBLJANA, SLOVENIA – Aim is to cut inappropriate antimicrobial therapy in febrile children while awaiting culture results.

  • 1
    News

    Reducing pediatric RSV burden is top priority

    June 11, 2019

    LJUBLJANA, SLOVENIA – “RSV is by far the hottest virus in the world,” said Dr. Terho Heikkinen.

  • 1
    News

    SGLT2 inhibitors prevent HF hospitalization regardless of baseline LVEF

    May 9, 2019

    NEW ORLEANS – “At least in my mind, we have more than enough evidence at this point to say that SGLT2 inhibitors are effective in preventing heart failure,” Dr. Mikhail Kosiborod said.

  • 1
    News

    PIONEER-HF Extension: Don’t stall starting sacubitril/valsartan

    April 14, 2019

    NEW ORLEANS – “The early improvement in postdischarge outcomes supports the in-hospital initiation of sacubitril/valsartan.” – Dr. Adam D. DeVore

Previous1 … 3 4 5 6 7 … 10Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences